The primary goal of ABA is to improve quality of life, and independence by teaching adaptive behaviors to children with autism, and to diminish problematic behaviors like running away from home, or self-injury by using positive or negative reinforcement to encourage or discourage behaviors over time. Environmental Therapy: Sensory Enrichment Therapy uses enrichment of the sensory experience to improve symptoms in autism, many of which are common to CDD. Medications: There are no medications available to directly treat CDD. Antipsychotic medications are used to treat severe behavior problems like aggressive stance and repetitive behavior patterns. Anticonvulsant medications are used to control seizures. References
Further reading
Maurice, Catherine (1993). Let me hear your voice: a familys triumph over autism. New York: Knopf. ISBN 978-0-679-40863-5. OCLC 26633221. Westphal A, Schelinski S, Volkmar F, Pelphrey K (February 2013). "Revisiting regression in autism: Hellers dementia infantilis. Includes a translation of Über Dementia Infantilis". J Autism Dev Disord. 43 (2): 265–71. doi:10.1007/s10803-012-1559-z. PMID 22677931. S2CID 3924122. Dobbs, David (2016). "The most terrifying childhood condition youve never heard of." Spectrum 6 July 2016, accessed 6 May 2017 at en:Childhood_disintegrative_disorder?action=edit,   oldid 778841596&wteswitched=1

External links
NIH/Medline
Omacetaxine mepesuccinate can cause fetal harm when administered to a pregnant woman. Women using HHT should avoid becoming pregnant and also avoid nursing while receiving HHT. Mechanism of action
Omacetaxine is a protein translation inhibitor. It inhibits protein translation by preventing the initial elongation step of protein synthesis. It interacts with the ribosomal A-site and prevents the correct positioning of amino acid side chains of incoming aminoacyl-tRNAs. Omacetaxine acts only on the initial step of protein translation and does not inhibit protein synthesis from mRNAs that have already commenced translation. == References ==